Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelodysplastic syndrome (MDS)
Closed
Phase 3
This trial is looking at rigosertib for people who have already had treatment for their myelodysplastic syndrome (MDS).
Myelodysplastic syndrome (MDS) causes the bone marrow to produce blood cells that aren’t mature and don’t function properly. This causes a drop in the normal blood cells.
Recruitment start: 31 March 2016
Recruitment end: 30 April 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ghulam Mufti
Onconova Therapeutics, Inc
Last reviewed: 30 Apr 2020
CRUK internal database number: 14391
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
